LAUSR

Objectives: Vascular mineralocorticoid receptors play a role in vascular tone and blood pressure regulation, might participate in the pathophysiology of circulatory failure during sepsis, and represent a potential therapeutic target in this disease. We aimed to study the effects of mineralocorticoids and the involvement of vascular mineralocorticoid receptors in murine endotoxic and human septic shock. Design: Experimental study. Setting: Translational investigation including animal research and in vitro experiments using human vascular cells and plasma from septic patients. Subjects: Adult male C57Black 6 mice, adult patients with septic shock. Interventions: Mice were injected with lipopolysaccharide and/or aldosterone. Human endothelial and smooth muscle cells were treated with pro-inflammatory cytokines with or without aldosterone, nuclear factor-&kgr;B inhibitor BAY 11-7082, or plasma from septic patients. Measurements and Main Results: Aldosterone improved 5-day survival, invasive arterial pressure, and in vivo and ex vivo arterial response to phenylephrine at 18 hours after induction of murine endotoxic shock. Both &agr;1-adrenoceptor and mineralocorticoid receptor expressions studied in mouse aortas were down-regulated at 6 and 18 hours in endotoxemic mice and restored in aldosterone-treated mice. Furthermore, tumor necrosis factor-&agr; decreased both mineralocorticoid receptor and &agr;1-adrenoceptor expressions within 5 hours in human vascular cells in a nuclear factor-&kgr;B pathway–dependent manner. Mineralocorticoid receptor expression was also blunted in human cells treated with plasma from septic patients. Conclusion: We found a beneficial effect of mineralocorticoids on survival, blood pressure, and vascular reactivity, associated with a restoration of &agr;1-adrenoceptor expression in endotoxic shock. Furthermore, blunted vascular mineralocorticoid receptor expression might participate in hemodynamic failure during sepsis.